Bowen Xing

619 total citations
22 papers, 458 citations indexed

About

Bowen Xing is a scholar working on Molecular Biology, Surgery and Oncology. According to data from OpenAlex, Bowen Xing has authored 22 papers receiving a total of 458 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 6 papers in Surgery and 4 papers in Oncology. Recurrent topics in Bowen Xing's work include Pancreatic function and diabetes (6 papers), Cell Adhesion Molecules Research (4 papers) and Neuroendocrine Tumor Research Advances (3 papers). Bowen Xing is often cited by papers focused on Pancreatic function and diabetes (6 papers), Cell Adhesion Molecules Research (4 papers) and Neuroendocrine Tumor Research Advances (3 papers). Bowen Xing collaborates with scholars based in China, United States and Australia. Bowen Xing's co-authors include Xin‐Yun Huang, Jianyun Huang, François Bordeleau, Cynthia A. Reinhart‐King, Bingqian Liu, J. Jillian Zhang, Xianxin Hua, Fang-Ke Huang, Zijie Feng and Xiaosong Ma and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Investigation and Nature Communications.

In The Last Decade

Bowen Xing

19 papers receiving 458 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Bowen Xing China 11 211 151 141 60 57 22 458
Lucia Minoli Italy 12 223 1.1× 135 0.9× 67 0.5× 40 0.7× 44 0.8× 31 455
Pushpankur Ghoshal United States 15 289 1.4× 81 0.5× 79 0.6× 29 0.5× 55 1.0× 23 520
С. В. Айдагулова Russia 11 238 1.1× 55 0.4× 160 1.1× 36 0.6× 27 0.5× 75 439
Marie‐Pier Thibault Canada 10 177 0.8× 107 0.7× 85 0.6× 26 0.4× 55 1.0× 17 437
Kevin O’Hayer United States 10 315 1.5× 263 1.7× 75 0.5× 24 0.4× 41 0.7× 18 568
Chetan K. Rane United States 8 305 1.4× 174 1.2× 90 0.6× 35 0.6× 54 0.9× 12 512
Cheng Yan China 13 346 1.6× 118 0.8× 75 0.5× 32 0.5× 55 1.0× 38 543
Monira Hoque Australia 13 390 1.8× 66 0.4× 86 0.6× 35 0.6× 65 1.1× 18 566
Meritxell Reverter Australia 9 420 2.0× 64 0.4× 102 0.7× 44 0.7× 57 1.0× 9 547
Amber Jean Tietgens United States 10 316 1.5× 48 0.3× 233 1.7× 33 0.6× 45 0.8× 12 591

Countries citing papers authored by Bowen Xing

Since Specialization
Citations

This map shows the geographic impact of Bowen Xing's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bowen Xing with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bowen Xing more than expected).

Fields of papers citing papers by Bowen Xing

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bowen Xing. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bowen Xing. The network helps show where Bowen Xing may publish in the future.

Co-authorship network of co-authors of Bowen Xing

This figure shows the co-authorship network connecting the top 25 collaborators of Bowen Xing. A scholar is included among the top collaborators of Bowen Xing based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bowen Xing. Bowen Xing is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lai, Chao‐Qiang, Bowen Xing, Hui Xu, et al.. (2025). Trends in type 2 diabetes-related deaths and disability-adjusted life years among smoking middle-aged and elderly adults in China, 1990–2021. Tobacco Induced Diseases. 23(December). 1–14.
2.
Xing, Bowen, Min Yang, Jun Shang, et al.. (2025). Splicing Shift of RAC1 Accelerates Tumorigenesis and Defines a Potent Therapeutic Target in Lung Cancer. Advanced Science. 12(33). e03322–e03322.
3.
Zheng, Yu, Weiwei Tang, Bowen Xing, et al.. (2025). Impact of lead exposure on global hypertensive CKD: YLDs/YLLs-based findings from 1990 to 2021 and projected trends to 2035. Ecotoxicology and Environmental Safety. 305. 119192–119192.
5.
Kong, Xiangchen, Chenxi Yang, Dan Yan, et al.. (2024). FXR/Menin-mediated epigenetic regulation of E2F3 expression controls β-cell proliferation and is increased in islets from diabetic GK rats after RYGB. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1870(5). 167136–167136. 3 indexed citations
6.
He, Guannan, et al.. (2024). Assessment of the economic impact of forecasting errors in Peer-to-Peer energy trading. Applied Energy. 374. 123750–123750. 2 indexed citations
7.
Ren, Jian‐Gang, Bowen Xing, Kaosheng Lv, et al.. (2023). RAB27B controls palmitoylation-dependent NRAS trafficking and signaling in myeloid leukemia. Journal of Clinical Investigation. 133(12). 24 indexed citations
8.
Feng, Zijie, Xin He, Xuyao Zhang, et al.. (2022). Potent suppression of neuroendocrine tumors and gastrointestinal cancers by CDH17CAR T cells without toxicity to normal tissues. Nature Cancer. 3(5). 581–594. 69 indexed citations
9.
He, Xin, Zijie Feng, Jian Ma, et al.. (2021). CAR T cells targeting CD13 controllably induce eradication of acute myeloid leukemia with a single domain antibody switch. Leukemia. 35(11). 3309–3313. 12 indexed citations
10.
Ma, Jian, Bowen Xing, Yan Cao, et al.. (2021). Menin‐regulated Pbk controls high fat diet‐induced compensatory beta cell proliferation. EMBO Molecular Medicine. 13(5). e13524–e13524. 10 indexed citations
11.
Jiang, Zongzhe, Shengrong Wan, & Bowen Xing. (2019). Wild-type menin is rapidly degraded via the ubiquitin-proteasome pathway in a rat insulinoma cell line. Bioscience Reports. 39(10). 2 indexed citations
12.
Xing, Bowen, Jian Ma, Zongzhe Jiang, et al.. (2019). GLP-1 signaling suppresses menin’s transcriptional block by phosphorylation in β cells. The Journal of Cell Biology. 218(3). 855–870. 9 indexed citations
13.
Wang, Limin, Bowen Xing, Jianyun Huang, et al.. (2017). G-Protein Gα13 Functions with Abl Kinase to Regulate Actin Cytoskeletal Reorganization. Journal of Molecular Biology. 429(24). 3836–3849. 5 indexed citations
14.
Xing, Bowen, Chengyang Liu, Ali Naji, et al.. (2017). Menin and PRMT5 suppress GLP1 receptor transcript and PKA-mediated phosphorylation of FOXO1 and CREB. American Journal of Physiology-Endocrinology and Metabolism. 313(2). E148–E166. 26 indexed citations
15.
Huang, Jianyun, Bingqian Liu, Bowen Xing, et al.. (2016). Improving fascin inhibitors to block tumor cell migration and metastasis. Molecular Oncology. 10(7). 966–980. 70 indexed citations
16.
Feng, Zijie, Lei Wang, Yanmei Sun, et al.. (2016). Menin and Daxx Interact to Suppress Neuroendocrine Tumors through Epigenetic Control of the Membrane Metallo-Endopeptidase. Cancer Research. 77(2). 401–411. 36 indexed citations
17.
Huang, Fang-Ke, Bowen Xing, Jianyun Huang, et al.. (2015). Targeted inhibition of fascin function blocks tumour invasion and metastatic colonization. Nature Communications. 6(1). 7465–7465. 106 indexed citations
18.
Yao, Qi, Bingqian Liu, Hui Li, et al.. (2014). C-terminal Src Kinase (Csk)-mediated Phosphorylation of Eukaryotic Elongation Factor 2 (eEF2) Promotes Proteolytic Cleavage and Nuclear Translocation of eEF2. Journal of Biological Chemistry. 289(18). 12666–12678. 17 indexed citations
19.
Xing, Bowen, Limin Wang, Dagang Guo, et al.. (2013). Atypical Protein Kinase Cλ Is Critical for Growth Factor Receptor-induced Dorsal Ruffle Turnover and Cell Migration. Journal of Biological Chemistry. 288(46). 32827–32836. 11 indexed citations
20.
Wang, Limin, Dagang Guo, Bowen Xing, et al.. (2011). Resistance to Inhibitors of Cholinesterase-8A (Ric-8A) Is Critical for Growth Factor Receptor-induced Actin Cytoskeletal Reorganization. Journal of Biological Chemistry. 286(35). 31055–31061. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026